Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

AYTU

AYTU News

Newswire

08:00

Aytu BioPharma Insider Transactions: Multiple Executives Buy Shares Amid Positive Signs

08:19

Aytu BioPharma shares rise 14.85% premarket after strategic realignment and EXXUA launch set for Q4 2025.

00:06

Aytu BioPharma Exceeds Expectations with Strong ADHD Portfolio Performance and Positive Q1 2026 Earnings Call Highlights

21:24

Aytu BioPharma Q1 2026 Earnings: $13.9M Revenue, Strong ADHD Portfolio Growth, and $17.3M Breakeven Target

19:06

Aytu BioPharma shares surge 10.19% after-hours on EXXUA antidepressant launch progress and patent extension.

View More

About AYTU

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More